Marquette Asset Management’s Fulcrum Therapeutics FULC Stock Holding History

Marquette Asset Management’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	+38,552	New	+$235K	0.02%	119
2024 Q2	–	Sell	-6,039	Closed	-$57K	–	197
2024 Q1	$57K	Sell	6,039 -21,828	-78%	-$195K	0.01%	138
2023 Q4	$188K	Hold	27,867	–	–	0.03%	75
2023 Q3	$124K	Hold	27,867	–	–	0.03%	92
2023 Q2	$92K	Buy	+27,867	New	+$81.9K	0.02%	126

Other funds holding FULC

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marquette Asset Management's FULC Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 38,552 shares worth $141K. The stake represents 0.02% of the portfolio and ranks #119 among its holdings. This is a return to the name: Marquette Asset Management previously reported a position in FULC as recently as Q1 2024.

Marquette Asset Management first reported a position in FULC in Q2 2023 and has held it in 5 quarters since. The position peaked at $188K in Q4 2023. 12 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Marquette Asset Management held 38,552 shares of Fulcrum Therapeutics worth $141K as of Q2 2026.
Fulcrum Therapeutics was a new Marquette Asset Management position in Q2 2026.
Fulcrum Therapeutics made up 0.02% of Marquette Asset Management's portfolio in Q2 2026, its #119 holding.
Marquette Asset Management first reported a position in Fulcrum Therapeutics in Q2 2023 and has held it in 5 quarters since.
Marquette Asset Management's Fulcrum Therapeutics position peaked at $188K in Q4 2023.
12 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.